System Transmission

Top Signal

100#1 JOB

Activity

2165Ripe

+919 today

System

Livenow

Terminal Asset View

stockNASDAQ

GRI

$2.54-13.01%

GRI Bio Inc

Overripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

30Overripe

Live Analysis Active

Company Mission

GRI Bio Inc develops therapies for autoimmune diseases by targeting natural killer T cells. Patients with conditions like lupus or rheumatoid arthritis might use these treatments to reduce inflammation. The company aims to make money by selling approved drugs or partnering with larger pharmaceutical companies if clinical trials are successful.

GRI

Industry Context

GRI Bio Inc operates in the biotechnology sector, focusing on developing treatments for autoimmune and inflammatory diseases. The company targets natural killer T cells to create novel therapies, which could address unmet medical needs. Success depends on clinical trial outcomes and regulatory approvals, making it a high-risk, high-reward investment.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

85Matrix

Market Momentum

52.5— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.1x— Normal Volume

Today's Change

-13.01%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

Gap Exposure-1

Large opening gap indicates potential short-term exhaustion.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing GRI across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 03:06 AM UTC

As-of As of 2026-03-16T02:51:12.577Z UTC (~15m delay).

Develops treatments for liver and lung diseases using natural killer cell therapies, aiming to generate revenue through drug development and partnerships.

Technical patterns are forming near $0, suggesting bullish momentum as the stock consolidates after recent gains. Watch for a breakout above this level to confirm upward movement.

Volume spiked 3x at $0, indicating retail interest because of positive news about clinical progress. Monitor if volume stays elevated to sustain the rally.

Industry trends in biotech innovation are driving strength, with price holding above $0, signaling resilience in a volatile sector. Watch for broader market conditions affecting small-cap stocks.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...